Veracyte | VCYT - 股票

金融业

USD

USD 1.41B

现金及等价物

USD 362.58M

USD 39.29M

USD 488.38M

USD 59.94M

USD 40.45M

USD 24.63M

USD 42.31M

824

EPS每股收益

USD 0.53

股本和储备

USD 1.26B

USD 101.97M

债务利息支出

USD 2K

USD 3.48M

USD 0

USD 2.5B

USD 41.15M

USD 116.01M

USD 24.63M

普通股股本

USD 79.05M

45.3

USD 40.63M

USD 140.6M

销售和管理费用

USD 43.31M

USD 20.55M

贸易债权人

USD 4.59M

应收帐款人

USD 44.66M

	股票	更改		日
Agilent	USD 1.06B		34M	2025-12
Anika Therapeutics	USD 18.79M		2.5M	2025-12
Arrowhead Research	USD -173.08M		173.08M	2024-12
Bruker	USD 1.2B		21.7M	2025-09
Exact Sciences	USD 166.2M		1.42M	2025-12
Heron Therapeutics	USD 54.57M		2.33M	2022-12
Illumina	USD 564M		26M	2025-12
Intrexon	USD 287K		68K	2022-12
Karyopharm Therapeutics	USD 3.97M		1.03M	2025-09
Laboratory Of America	USD 534.7M		13.2M	2025-12
Ligand Pharmaceuticals	USD 9.13M		2.77M	2025-12
Myriad Genetics	USD 30.6M		1000K	2025-12
Rigel Pharmaceuticals	USD 13.3M		2.88M	2025-09
Roche Holding	CHF 7.6B		9M	2025-06
Siemens	EUR 10.26B		906M	2025-09
Sonic Healthcare	AUD 208.83M		3.83M	2024-06
Thermo Fisher Scientific	USD 5.43B		320M	2025-12
Veracyte	USD 20.55M		219K	2025-12
Waters	USD 572.37M		570K	2025-12